HopeStage
Back to all studies
CompletedNCT00317460

Psychosocial support with buprenorphine for opioid dependence in HIV care

About this titleRead the official source — NCT00317460
Behavioural studyAges 18+United StatesAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 18 years.

Listed locations
New HavenSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateSeptember 2005
Recruitment status
Completed
Enrollment listed in the registry
52
Sponsor
Yale University
Sponsor type
University
Study type
Behavioral
Intervention type
Behavioural, Other
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT00317460
Official title
Show the full official title

On-Site Addiction Treatment With Buprenorphine in HIV Clinical Care Settings

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

New Haven

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Yale University, a university.

Who was this study for?

Listed age limits: from 18 years.

Want to explore more studies?

Explore studies